Recent Quotes (30 days)

You have no recent quotes
chg | %

Cipher Pharmaceuticals Inc  

(Public, TSE:CPH)   Watch this stock  
Find more results for TSE:DND
-0.34 (-2.84%)
Delayed:   3:31PM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 11.31 - 11.99
52 week 8.81 - 19.52
Open 11.99
Vol / Avg. 30,706.00/51,946.00
Mkt cap 301.16M
P/E 15.29
Div/yield     -
EPS 0.76
Shares 25.90M
Beta -0.44
Inst. own     -
Jun 2, 2015
Cipher Pharmaceuticals Inc at Jefferies Global Healthcare Conference
May 13, 2015
Cipher Pharmaceuticals Inc Annual Shareholders Meeting
May 13, 2015
Q1 2015 Cipher Pharmaceuticals Inc Earnings Call
May 13, 2015
Q1 2015 Cipher Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 33.83% 63.96%
Operating margin 46.48% 61.27%
EBITD margin - 67.80%
Return on average assets 15.80% 31.23%
Return on average equity 19.22% 40.69%
Employees 13 -
CDP Score - -


2345 Argentia Road, Suite 100A
+1-905-6025840 (Phone)
+1-905-6020628 (Fax)

Website links


Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company focused on dermatology. The Company acquires products that fulfill medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. The Company's dermatology products include Sitavig, Absorica, Epuris, Beteflam, Dermadexin, Pruridexin, Ozenoxacin, CF101, ASF-1096 and Nanolipolee-007. The Company's other products include Lipofen, Conzip and Durela.

Officers and directors

Gerald P. McDole Independent Chairman of the Board
Age: 75
Shawn Patrick O'Brien President, Chief Executive Officer
Norman C. Evans Chief Financial Officer, Secretary
Age: 60
Joan Chypyha President, General Manager - Canada
Joseph Pecora President and General Manager - USA
Linda Melanie Angaritis Vice President - Global Regulatory Compliance and Quality
Louise Blythe Vice President - Regulatory Affairs
Lynne Bulger Vice President - Medical and Clinical Affairs
Brian Rosenberger Vice President - Alliance and Strategic Portfolio Management
Peter Weiler Vice President - Business Development